Alpha N Acetylglucosaminidase Market is anticipated to grow at a significant CAGR during the forecast period. Alpha N acetylglucosaminidase is a protein associated with Sanfilippo syndrome. It is an enzyme with systematic name alpha-N-acetyl-D-glucosaminide N-acetylglucosaminohydrolase. This enzyme is located in lysosomes, compartments within cells that digest and recycle different types of molecules. The major factor attributable to market growth includes the growing prevalence of Sanfilippo syndrome all over the globe. Sanfilippo syndrome is a rare genetic metabolism disorder. A change in a single gene makes a child’s body unable to break down certain carbohydrates (sugars). This leads to serious problems in the brain and nervous system. There is no cure yet for Sanfilippo syndrome. However, alpha-N-acetylglucosaminidase is involved in the stepwise breakdown of large molecules known as glycosaminoglycans (GAGs).
GAGs are composed of sugar molecules that are linked together to form a long string. To break down these large molecules, individual sugars are removed one at a time from one end of the molecule. Alpha-N-acetylglucosaminidase removes a sugar called N-acetylglucosamine when it is at the end of the GAG chain. Another major factor propelling the growth of the global alpha N acetylglucosaminidase market include the ongoing clinical trials. Clinically, 3 different phenotypes of alpha-N-acetylglucosaminidase have been discovered. Type I is an infantile-onset neuroaxonal dystrophy with rapid neurodegenerative changes manifested by severe psychomotor retardation, cortical blindness, and myoclonal seizures. Lesions are limited to the nervous system, however, there is diffuse osteopenia. Type II is a chronic condition manifested as mild intellectual retardation, angiokeratoma corporis diffusum, and slight facial features. Type III is an intermediate form.
To Request a Sample of our Report on Alpha N Acetylglucosaminidase Market: https://www.omrglobal.com/request-sample/alpha-n-acetylglucosaminidase-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Abeona Therapeutics Inc., and BioMarin Pharmaceutical Inc. among others.
Alpha N Acetylglucosaminidase Market Report by Segment
By Type
- Lesinidase Alfa
- ABO-101
- BMN-250
- EGT-201
- Others
By Application
- In-Patient
- Out-Patient
A full Report of Alpha N Acetylglucosaminidase Market is Available @ https://www.omrglobal.com/industry-reports/alpha-n-acetylglucosaminidase-market
Alpha N Acetylglucosaminidase Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/alpha-n-acetylglucosaminidase-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
